Veracyte (NASDAQ: VCYT) reported Q4 EPS of $0.36, $0.26 better than the analyst estimate of $0.10. Revenue for the quarter came in at $118.6 million versus the consensus estimate of $116.68 million.

GUIDANCE:

Veracyte sees FY2025 revenue of $470-480 million, versus the consensus of $486.5 million.

For earnings history and earnings-related data on Veracyte (VCYT) click here.